{
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "document": "CDC_Influenza_vaccines",
  "verification_stats": {
    "total_extracted": 1,
    "verified": 0,
    "rejected": 1,
    "verification_rate": 0.0
  },
  "verified_evidence": [],
  "rejected_evidence": [
    {
      "id": 1,
      "quote": "RIV4 (recombinant HA vaccine)",
      "reason": "does not support claim",
      "original_explanation": "This quote identifies RIV4 (Flublok) as a recombinant HA vaccine, which supports the claim that it is produced using recombinant technology rather than traditional egg-based methods."
    }
  ],
  "model_used": "gpt-4.1"
}